Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma

J Clin Oncol. 2005 Jan 1;23(1):247-8. doi: 10.1200/JCO.2005.05.282.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Agammaglobulinemia / chemically induced*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Cyclophosphamide / administration & dosage*
  • Doxorubicin / administration & dosage*
  • Humans
  • Lymphoma, AIDS-Related / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male
  • Middle Aged
  • Prednisone / administration & dosage*
  • Rituximab
  • Vincristine / administration & dosage*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol